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Abstract
Background: Previous studies have shown that disruption of GABA signaling in mice via mutations in the Gad1, Gabrb3 or
Viaat genes leads to the development of non-neural developmental defects such as cleft palate. Studies of the Gabrb3 and
Gad1 mutant mice have suggested that GABA function could be required either in the central nervous system or in the
palate itself for normal palatogenesis.
Methodology/Principal Findings: To further examine the role of GABA signaling in palatogenesis we used three
independent experimental approaches to test whether Gad1 or Viaat function is required in the fetal CNS for normal palate
development. We used oral explant cultures to demonstrate that the Gad1 and Viaat mutant palates were able to undergo
palatogenesis in culture, suggesting that there is no defect in the palate tissue itself in these mice. In a second series of
experiments we found that the GABAA receptor agonist muscimol could rescue the cleft palate phenotype in Gad1 and
Viaat mutant embryos. This suggested that normal multimeric GABAA receptors in the CNS were necessary for normal
palatogenesis. In addition, we showed that CNS-specific inactivation of Gad1 was sufficient to disrupt palate development.
Conclusions/Significance: Our results are consistent with a role for Gad1 and Viaat in the central nervous system for normal
development of the palate. We suggest that the alterations in GABA signaling lead to non-neural defects such as cleft palate
as a secondary effect due to alterations in or elimination of fetal movements.
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Introduction
The mechanism leading to non-neural developmental defects in
mice homozygous for null alleles of the genes Gad1, Gabrb3 or Viaat
(Slc32a1) has been an enigma [1,2,3,4,5]. Each of these genes
encodes a component required for GABA neurotransmission
including GABA synthesis (Gad1), GABA vesicular transport (Viaat)
and the postsynaptic response to GABA (Gabrb3). The most
prominent phenotype noted by us and other investigators has been
the surprising presence of a cleft palate in neonatal mice
homozygous for null mutations in Gad1, Viaat and Gabrb3
[3,4,5,6]. In addition, possible associations between human oral
clefts and alleles of GAD1 or GABRB3 have been reported [7,8,9].
Overall, this literature suggests that understanding the develop-
mental mechanisms that lead to oral clefts in the Gad1, Viaat and
Gabrb3 mice might lead to new insights into the origin of human
oral clefts, a common congenital disorder.
Several studies have been performed to determine whether
GABA signaling is required in the CNS or in peripheral tissues for
normal palate formation in Gad1 and Gabrb3 mutant mice. These
studies have drawn different conclusions depending on the gene
examined and the experimental approach taken. In the case of
Gabrb3, two studies support a role in non-neural cell types for
normal palatogenesis. In one case, transgenic expression of Gabrb3
from a neuron-specific enolase promoter failed to complement the
cleft plate phenotype of a Gabrb3 null mutation, suggesting that
non-neural expression of Gabrb3 was required for normal palate
formation [10]. Another study showed that palate development
was normal in a pan-neuronal-specific knockout of the Gabrb3
gene, again suggesting that Gabrb3 function was required in the
palate or other craniofacial structures for normal palatogenesis
[11]. In the case of Gad1, previous studies indicated that the cleft
palate phenotype of Gad1-/- pups was due to a lack of fetal oral
movements as well as inhibition of palate shelf elevation due to the
abnormal position of the tongue between the shelves [12,13]. This
analysis of the Gad1 phenotype was consistent with a requirement
for GABA signaling in the CNS for normal fetal movement that in
turn allows normal palate development. However, several papers
have reported GABA, Gabrb3 or Gad1 expression in developing
craniofacial structures such as the palate, oral epithelium, tooth
placodes or condensations, tooth buds and palate medial edge
epithelium [4,10,14,15,16,17]. The presence of Gad1 mRNA or
protein as well as GABA in these structures is consistent with a
functional role for GABA signaling in the palate. In addition, Gad1
gene expression has been detected in several epithelial placodes as
well as in non-neural tissues that are developmental signaling
centers, suggesting a role for GABA in developmental processes
outside of the CNS [18]. In the case of Viaat, cleft palate and body
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knockout mouse [5]. However, that report did not examine the
mechanisms underlying the non-neural phenotypes in the Viaat
mutants.
In this study we used three independent experimental
approaches to show that the non-neural defects in Gad1 and
Viaat mutant mice are due to loss of gene function within the
CNS during development. We performed a pharmacological
rescue experiment to show that the GABAA agonist muscimol can
suppress the cleft palate phenotype in Gad1 and Viaat mutant
embryos. The ability of muscimol to rescue the cleft palate
phenotype of Gad1 and Viaat mutants suggests that multimeric
GABAA receptors are downstream of Gad1 and Viaat in palate
formation, a pathway that is most consistent with GABA
signaling in the CNS. In addition, we used a serum free explant
culture system to show that oral explants derived from Gad1
lacz -/-
and Viaat
lacZ -/- embryos were competent to undergo normal
palate shelf elevation and fusion when removed from their
normal oral context. This experiment provided additional
evidence that Gad1 and Viaat function are not directly required
for palate formation. A third experimental approach was to
inactivate Gad1 specifically in neural precursor cells throughout
the CNS. We took advantage of a Gad1 conditional allele to
demonstrate that an early neural precursor specific knockout of
Gad1 was sufficient to cause a cleft palate phenotype in mutant
embryos. Our work strongly supports the idea that the cleft palate
phenotype in Gad1 and Viaat knockout mice is due to a loss of
GABA signaling in the CNS rather than in craniofacial tissues.
We interpret our results in the context of other studies that have
documented a role for fetal movement in the development of
tissues and structures outside of the CNS. We suggest that the
phenotypes seen in the Viaat and Gad1 knockout mice belong to a
family of fetal defects in non-neural tissues that are caused by a




All work with mice conformed to the stipulations of the
University of Georgia Institutional Animal Care and Use
Committee. The University of Georgia animal welfare assurance
number is A3437-01 which expires on 11/30/2011. The Viaat
lacZ
knockin/knockout allele was generated by gene targeting in ES
cells. Genomic clones containing the mouse Viaat locus were
isolated from a 129/SvEv lambda phage library. A 5.2-kb
fragment immediately upstream of the translation start site was
used as a 59 arm and a 2.8-kb fragment starting downstream of the
start codon was used as a 39 arm. A b-galactosidase reporter/
neomycin resistance cassette was placed into an NcoI site in the
Viaat first exon. This NcoI site includes the start codon of the Viaat
gene [19]. After linearization the targeting vector was electropo-
rated into GSI-1 ES cells (obtained from Genome Systems Inc.).
Four targeted ES cell lines were injected into blastocysts and one
chimera transmitted the knockout allele to the founder offspring.
The Viaat knockout mice used in this study had been crossed for 4–
10 generations to the C57Bl/6J background. The Gad1
lacZ
knockin-knockout mice have been described previously [20].
The strain carrying the floxed conditional allele of the Gad1 gene
was obtained from Dr. Richard Palmiter. This strain has been
described previously [6]. The Nestin-Cre strain [21] was obtained
from The Jackson Laboratory. Fetal mice were genotyped using
yolk sac DNA and adult mice were genotyped using tail DNA as
template for PCR.
Histological analysis
For paraffin sections, embryos were fixed in Bouin’s solution at
4uC from 3 hours to overnight depending on the embryonic stage
and washed in phosphate buffer (pH 7.3) overnight. Then the
embryos were then dehydrated in a graded series of ethanol,
equilibrated with xylene, embedded in paraffin and sectioned at a
thickness of 10 mm. Sections were stained with Mayer’s hematox-
ylin (Sigma) and eosin solution after dewaxing with xylene, and
mounted on slides.
Whole mount lacZ histochemistry was performed on E9.5-
E14.5 day old heterozygous Viaat embryos. The embryos were
fixed in 0.4% paraformaldehyde (PFA), 100 mM sodium
phosphate pH 7.3, 2 mM MgCl2, 5 mM EGTA for 30–60
minutes and then rinsed in 100 mM sodium phosphate pH 7.3,
2m M ,M g C l 2, 0.01% sodium deoxycholate, 0.02% igepal for at
least 3 hours and stained in 100 mM sodium phosphate pH 7.3,
2m M M g C l 2, 0.01% sodium deoxycholate, 0.02% igepal,
5 mM potassium ferricyanide, 5 mM potassium ferrocyanide,
1m g / m lX - g a la t3 7 uC. After staining, embryos were washed in
PBS and postfixed in 4% PFA/PBS for 1 hour at room
temperature.
Palate Explant Culture
For the explant cultures we developed a new serum free culture
system that combined a serum-free in vitro mouse embryo culture
technique [22] with a previously described method for dissecting
the palatal region for in vitro culture [23]. E13.5 Mouse embryos
were dissected in Knockout DMEM (Invitrogen). The mandibular
region including tongue was removed from the embryo head and
the brain tissues were dissected out in parallel at the level of the
eyes by using an aseptic scalpel. Also, the remaining tissues from
the hindbrain and cerebellum including their covering skin were
completely removed with fine forceps. The explants were cultured
in a rolling bottle apparatus from BTC Engineering (Cambridge,
UK) at 37uC in 3 ml of serum-free media per palate in an
atmosphere of 95%O2/5% CO2. The culture medium was
replaced after 24 hr. After culture for 1 or 2 days, explants were
processed for paraffin embedding and H&E staining as described
above.
Muscimol rescue experiment
To generate homozygous offspring for the rescue experiments,
we intercrossed Gad1 or Viaat heterozygotes. To increase the
likelihood that litters were within comparable ranges of gestational
age matings were set up at 9pm and the mice were separated at
9am the next day. Muscimol injections were done within the same
time window for each set of pregnant dams. This was done to
improve the reproducibility of the results between different litters.
In the Gad1-/- rescue experiment, muscimol was injected into the
abdominal cavity of pregnant dams every 24 hours from E13.5 to
E15.5. For the Viaat-/- rescue experiment, muscimol was injected
every 12 hours from E13.5 to E16.0. We used 4 mg/kg of
muscimol for each injection. This is a dosage that results in
obvious sedation of the mice [24].
RT-PCR
RT-PCR analysis of mRNA expression was performed as
previously described [20]. The primer sequences and expected
sizes for each gene are as follows:
Viaat (578 bp) 59-GTCGAGGGAGACATTCATTATCAG-
39, 59-GTACACAGCAGACTGAACTTGGAC-39
Gad1 (302 bp) 59-CCTTCGCCTGCAACCTCCTCGAAC-39,
59-GCGCAGTTTGCTCCTCCCCGTTCTT-39
Gad1 and Viaat Mutants
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CACTCAC-39,5 9-CAATCTTGAGTGAGTTGTCATATTTCTCG-
T-39
Gabrb3 (356 bp) 59-GAAATGAATGAGGTTGCAGGCAGC-
39,5 9-CAGGCAGGGTAATATTTCACTCAG-39
Ucp-1 (593 bp) 59-TAGGTATAAAGGTGTCCTAGGGA-39,
59-CGCTTGGGTACTGTCCTGG-39
Results




We generated mice carrying lacZ-tagged knockin/knockout alleles
of Viaat and Gad1 for genetic studies and to facilitate the detection of
Viaat or Gad1 expressing cells by b-galactosidase histochemistry. The
Viaat
lacZ and Gad1
lacZ mice add to the existing mouse resources that
express lacZ or fluorescent proteins in GABAergic and/or glycinergic
neurons (Table 1). The strains listed in Table 1 carry marker gene
knockin alleles or BAC transgenes wherein marker gene expression is
likely to recapitulate most or all of the expression pattern of the
endogenous gene. Additional transgenic lines have been generated
with smaller segments of the regulatory regions of these genes
[25,26,27]. Previously described knockin/knockout alleles of Gad1
and Viaat were also tagged with marker genes, but expression of the
marker from the knockin allele could not be detected [4,5]. Our
Viaat
lacZ knockin allele was generated by inserting a lacZ coding
sequence into the first exon of the Viaat gene (Figure 1A) [19].
Targeted ES cell clones and mice were identified by Southern blot
analysis of genomic DNA (Fig. 1B) and RT-PCR analysis showed
that Viaat transcripts were undetetctable in the homozygous Viaat
lacZ
offpring (Fig. 1C). A similar strategy was used to generate a lacZ
tagged allele of Gad1. The design of the Gad1
lacZ allele was described
previously [20]. In both strains the neo cassette was removed by
crossing the founder mice to a germline Cre deleter strain [28]. The
studies described here used mice carrying the neo-deleted lacZ
knockin/knockout alleles of Viaat and Gad1.
To validate the expression of the lacZ marker from the Viaat
lacZ
and Gad1
lacZ knockin alleles, we performed an initial analysis of b-
galactosidase expression in the knockin mice. Whole mount and
section Xgal histochemistry revealed expression patterns in both
mouse strains that mirrored our previously published in situ
hybridization results (Fig. 1D)[18,19].
Viaat is required for normal palate and ventral body wall
development
To define the spectrum of mutant phenotypes in the Viaat
lacZ
knockout mouse we examined newborn progeny from intercrosses
of Viaat
lacZ heterozygous mice. The Viaat
lacZ-/- progeny were
immediately identifiable due to their lack of movement, hunched
posture, and failure to breathe (Fig. 2A). All Viaat
lacZ homozygous
offspring died at or immediately prior to birth. Examination of the
pups showed that the Viaat
lacZ -/- newborns exhibited a cleft
secondary palate, umbilical hernia and small bumps under the skin
on the dorsal side of the cervical region (Fig. 2B-2F). Histological
examination ofparaffinsections showedthat none ofthe Viaat
lacZ -/-
newborns examined had inflated their lungs at birth indicating an
early fundamental defect in respiratory function (data not shown).
We compared the Viaat
lacZ -/- newborn phenotype to that of
Gad1
lacZ-/- newborns. Nearly all (98%) of the newborn Viaat
lacZ
homozygotes exhibited umbilical hernias (Fig. 2F, G). Examination
of the Gad1
lacZ homozygotes revealed a similar, but less frequent
(85%) umbilical hernia phenotype that had not been previously
reported. Histological sections of Viaat
lacZ homozygotes revealed that
this defect was indeed an umbilical hernia, not an ompahalocele as
previously reported for the Viaat homozygous mice [5]. Omphalocele
is a severe body wall defect that results in an abnormally large
umbilical ring usually exposing the gut and liver [29,30]. In contrast,
an umbilical hernia is caused by a failure to retract the umbilical
hernia that occurs normally during development [29,30]. These
phenotypes suggest that Gad1 and Viaat functions are not necessary
for body wall formation per se but are instead required for the
retraction of the umbilical hernia during development. In both
genotypes, palate shelf elevation fails to occur at E14.5 and all Gad1
and Viaat mutants were born with cleft secondary palates (Fig. 3A-H
and data not shown).
We also examined the unusual ‘‘bumps’’ on the dorsal cervical
region of the Viaat
lacZ -/- mice (Fig. 2D). These ‘‘bumps’’ were not
present in Gad1 mutant newborns. Our analysis indicates that they
are clumps of displaced brown fat since they resemble mouse brown
fat in H&E stained paraffin sections and RNA extracted from the
bumps contained very high levels of Ucp1 mRNA (data not shown).
Ucp1 is a specific marker of brown fat [31,32]. In a newborn mouse
the major deposit of brown fat is found in the intrascapular region,
with additional deposits in various locations in the cervical region
[33]. Presumably, the hunched posture and the apparent muscular
paralysis exhibited by the Viaat
lacZ homozygotes leads to the
displacement of these fat deposits to this abnormal location.
Viaat is not expressed in the developing palate
Previousstudies have suggested the possibilitythat GABA may be
functioning as a signaling molecule in non-neuronal tissues during
development [10,18,34]. Previous gene expression studies have
shown that Gabrb3 receptorsubunit and Gad1 mRNAsareexpressed
in the developing palate and teeth as well as in a variety of other
non-neuronal cell types [10,15,16,18,35]. If Viaat function is
required in the palate or craniofacial structures it should be
expressed in these tissues. To determine whether Viaat mRNA is
expressed in the developing palate, we examined the expression of
Gabrb3, Gad1 and Viaat in mRNA from dissected palatal shelves
from E13.5 and E14.5 day old mice. Using RT-PCR we easily
detected Gad1 and Gabrb3 transcripts but could not detect Viaat
mRNA in this tissue (Fig. 4). These results indicate that Viaat is not
expressed in the palatal shelves at the time of palate shelf elevation
and fusion. The lack of Viaat expression in the palate suggests that its
function is not required in the palate for its normal development.
Palate explants from Gad1 and Viaat mutants can
undergo shelf elevation and fusion
A previous study showed that oral explants made from Gad1
knockout mice could undergo palatal shelf elevation in embryo
Table 1. Knockin and transgenic mice that express lacZ or
EGFP in GABAergic and/or glycinergic neurons.
Mouse strain Reference
Gad1
lacZ knockout/knockin This study
Viaat
lacZ knockout/knockin This study
Gad1-EGFP knockout/knockin [17]
Gad1-EGFP BAC transgenic [76]
Gad2-EGFP BAC transgenic www.gensat.org
Viaat (Slc32a1)-EGFP BAC transgenic www.gensat.org
Glyt2 (Slc6a5)-EGFP BAC transgenic www.gensat.org; [77]
doi:10.1371/journal.pone.0009758.t001
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utero surgical manipulations that suggested that removal of the
tongue was sufficient to allow normal palatogenesis in the Gad1
knockout embryos. Building on these previous results, we performed
a series of explant experiments to test whether there is a requirement
for GABA signaling within the developing palate shelves for normal
shelf elevation and fusion in the Viaat
lacZ -/- embryos and control
littermates. This experiment is a simple way to test whether the
mutant palate is capable of undergoing normal morphogenesis when
removed from the context of the embryo. We developed an explant
culture system that used a previously described dissection protocol to
generate explants from the maxillary region of the E13.5 mouse
embryos [23]. Explants dissected using this protocol were also used
in the previous analysis of palate development in the Gad1 mutant
explants [13]. We cultured the explants in a serum free and
chemically defined medium that we had previously developed for
mouse embryo culture [22]. In this system wild type explants
underwent palate shelf formation, growth, elevation and fusion
thereby recapitulating the normal events in palatogenesis (Fig. 5A-F).
Explants from Viaat
lacZ-/- and Gad1
lacZ-/- embryos also underwent
shelf elevation and fusion in this explant culture system (Fig. 5G-L).
The absence of cleft palate in the Viaat and Gad1 mutant explants
Figure 1. Targeted disruption of the Viaat gene in mice. (A) A schematic representation of the Viaat wild-type genomic locus (Genomic
Structure), the targeting vector (Targeting Construct), and the mutant locus (Targeted structure) are shown. A LacZ sequence was inserted into an
NcoI site at the Viaat start codon. The lox sites that flank the Neo resistance cassette are indicated with two arrowheads in the region immediately 39
to the lacZ sequence. The locations of the 59 (59 Probe) and 39 (39 Probe) flanking probes used in characterizing the Viaat allele are indicated above
the map of the wild type Viaat locus. The positions of the restriction sites used in the Southern blot analysis of genomic DNA from ES cells are
indicated by single letters. Restriction sites are indicated as follows: H (HindIII), Nc (NcoI), A (Asp718) and N (NotI). (B) Southern blot analysis of
genomic DNA from a wild type parental ES cell line (+/+) and a targeted ES cell line used to generate the Viaat
lacZ mouse (+/-) are shown. In genomic
DNA digested with Asp718 the 39flanking probe hybridized to a 15.5 kb wild type fragment and a 10.9 kb from the targeted allele (Asp718 panel) and
in genomic DNA digested with HindIII this probe hybridized to a 12.1 kb wild type band and a 9.8 kb mutant band (HindIII panel). (C) RT-PCR analysis
of cDNA from wild-type (+/+) , heterozygous (+/2), and mutant embryo brain at E16.5. For each genotype RT-PCR was performed on RNA that had
been reverse transcribed (+ lanes) and RNA that had not been incubated with reverse transcriptase (2) to control for non-specific amplification.
GAPDH primers were used as a positive control. (D) Localized expression of b-galactosidase activity in Viaat
lacZ and Gad1
lacZ heterozygotes. The
panels from left to right show b-galactosidase activity in E11.5, and E14.5 Viaat
lacZ embryos and in E12.5 and E14.5 Gad1
lacZ embryos.
doi:10.1371/journal.pone.0009758.g001
Gad1 and Viaat Mutants
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explants and shows that palates from the Viaat
lacZ mutants are also
able to undergo palatogenesis in this system. In total we tested 5
Viaat
lacZ mutant explants from 3 different litters and 3 Gad1
lacZ
mutant explants derived from 3 different litters. Wild type and
heterozygous explants from these litters served as controls. In all
cases the Viaat
lacZ and Gad1
lacZ mutant explants underwent palatal
shelf outgrowth and elevation in culture. In both the mutants and
controls all of the palatal shelves fused to some extent with most of
the explants exhibiting nearly complete fusion. There was no
difference in the overall extent of fusion observed in control and
mutant explants. Normal palate shelf elevation in the explants is
consistent with there not being a requirement for GABA signaling
within the palate for normal palatogenesis. However, on their own
the explant experiments cannot completely exclude a possible role
for GABA in the palate shelf itself.
The GABA agonist muscimol suppresses the cleft palate
phenotype in the Viaat and Gad1 homozygous embryos
T h ep r e s e n c eo fac l e f tp a l a t ep h e n o t y p ei nGad1, Viaat and Gabrb3
mutant mice suggests that the three genes function in a GABA
signaling pathway required for palatogenesis. If this signaling pathway
Figure 2. Viaat mutants exhibit cleft palate and umbilical hernia. (A) Gross morphology of a Viaat
lacZ (2/2) mutant at E18.5 with hunched
posture as compared to a wild type E18.5 littermate (+/+). (B, C) Examination of E17.5 embryos showed that all of the Viaat
lacZ mutants exhibited a
cleft palate (C) as compared to wild type (B). (D) Viaat mutants have small subcutaneous bumps on the dorsal side of cervical region. (E, F) Compared
to wild type (E) nearly all of the Viaat
lacZ mice exhibited an umbilical hernia (F). (G) Gad1
lacZ mutant E17.5 mice also displayed a similar hernia
phenotype.
doi:10.1371/journal.pone.0009758.g002
Figure 3. Viaat mutants exhibit delays in palate shelf elevation. (A-D) H&E stained coronal sections showing normal palatogenesis in wild
type E13.5, E14.5, E15.5 and E18.5 mice. (E-H) Coronal sections of Viaat
lacZ homozygous mutants at E13.5, E14.5, E15.5 and E18.5, showing a failure of
palate shelf elevation in the mutants. P, palate; PS, palatal shelf; OC, oral cavity; T, tongue.
doi:10.1371/journal.pone.0009758.g003
Gad1 and Viaat Mutants
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phenotype of the Gabrb3 knockout mouse, then specific pharmacolog-
ical agonists of GABAA receptors might suppress or ‘‘rescue’’ the
phenotypes seen in Gad1
lacZ -/- and Viaat
lacZ -/- embryos. We tested
whether the specific GABAA agonist muscimol can suppress the non-
neural phenotypes of the Gad1 and Viaat homozygous embryos. We
chose to use muscimol as an agonist because it is a potent GABAA
receptor agonist that crosses the placental barrier and it binds to the
same binding pocket on pentameric GABAA receptors as GABA
[36,37]. Since muscimol binds to a pocket formed by an alpha and a
beta GABAA subunit in a multimeric GABAA receptor, any rescue of
the Gad1
lacZ or Viaat
lacZ mutant phenotypes by muscimol would suggest
that multimeric GABAA receptors were the downstream target of Gad1
or Viaat function [36,38,39,40].
We injected muscimol into pregnant Viaat
lacZ +/- or Gad1
lacZ +/-
dams that had been mated with Viaat
lacZ +/- or Gad1
lacZ +/- males
respectively. Multiple muscimol injections from E13.5-E16 days
were performed and the resulting offspring were removed at E17.5
days for examination. IP injection of muscimol into the pregnant
dams did suppress the development of cleft palate in Viaat
lacZ -/-
and Gad1
lacZ-/- mice but did so to different extents in the two
genotypes. Muscimol injection suppressed the formation of cleft
palate in about 20% of the Viaat
lacZ homozygous mutant embryos
and in about half of the Gad1 homozygous mutant embryos
(Table 2). Since the cleft palate phenotype is fully penetrant in
Viaat and Gad1 homozygous fetuses and newborns, the rescue of
the cleft palate phenotype in mutant embryos exposed to
muscimol is quite clear. Histological analysis of rescued Viaat
lacZ
-/- E17.5 embryos showed that palate shelf elevation and fusion
had occurred in all of the rescued homozygotes while in the case of
the Gad1
lacZ -/- rescued embryos palate shelf elevation and fusion
had occurred in 2 of the 7 rescued homozgyotes while shelf
elevation without fusion had occurred in the other 5 rescued
Gad1
lacZ-/- fetuses.
Gad1 function in the CNS is required for normal palate
formation
To perform a genetic test of the requirement for Gad1 function
in the CNS for normal development we examined the phenotype
of mice with a CNS-specific knockout of Gad1. Because palate shelf
elevation and fusion occur between E13.5 and E14.5 we chose to
inactivate Gad1 throughout the CNS in stem cells and progenitors
well before these events in palate morphogenesis. To inactivate
Gad1 in the early CNS we used a well-characterized transgenic line
(NesCre) that expresses Cre under the control of the Nestin
regulatory sequences [21]. The NesCre strain expresses Cre
exclusively in neural precursors starting at E9.5 days and by E11.5
days the expression of Cre activity is widely and uniformly
distributed throughout the nervous system [21,41,42,43]. This
strain is known to lack any detectable cre expression in the
craniofacial region [44]. The floxed allele of Gad1 used in our
experiments has been described previously [6,45].
To generate offspring with a CNS specific inactivation of Gad1
we crossed Gad1
lacZ/+; NesCre mice to Gad1
flox/Gad1
flox mice. To
confirm that Gad1 had been inactivated specifically in the CNS of
the Gad
flox/Gad
lacZ ; NesCre/+ offspring from this cross we used RT-
PCR to measure Gad1 mRNA levels in RNA isolated from
dissected palatal shelves and brain from E14.5 embryos. The RT-
PCR analysis showed that the amount of Gad1 mRNA in the
palatal shelves of the CNS specific Gad1 knockout embryos
(Gad
flox/Gad
lacZ; NesCre) was equivalent to controls, while Gad1
mRNA levels in the CNS were greatly reduced as compared to the
control embryos (Fig. 6). Examination of Gad
flox/Gad1
lacZ; NesCre
embryos at E17.5 showed that the cleft palate and the body wall
phenotypes were present in the CNS-specific knockout. In total,
we found a complete cleft palate in 9 out of the 11 Gad
flox/Gad1
lacZ
NesCre E17.5 embryos that we examined. This cleft palate
phenotype was identical to that seen in Gad1 mutant fetuses and
newborns. We also found that 6 of the CNS specific E17.5 Gad
flox/
Gad
lacZ; NesCre/+ exhibited an umbilical hernia. This genetic test
demonstrated that Gad1 function was required within the CNS for
normal development of the non-neural tissues affected in the Gad1
knockout.
Discussion
There have been numerous observations published over the last
25 years that implicate GABA signaling in the normal develop-
ment of non-neural tissues [2,3,4,10,11,14,18,34,46,47,48]. A role
for GABA signaling in non-neural tissues is plausible given the fact
that GABA and other neurotransmitters have well-documented
roles in the development of tissues and cell types outside of the
CNS. A striking and prominent example of this was a recent
report demonstrating that activation of GABAA receptors alters
embryonic stem cell proliferation in cell culture as well as cell
proliferation in mouse blastocyst stage embryos [48]. These cell
types exist prior to the earliest formation of the CNS, clearly
demonstrating a role for GABA signaling in a completely non-
neuronal context. In addition, serotonin, dopamine, acetylcholine,
epinephrine and norepinephrine each play important roles in the
development, maintenance and/or function of organs and tissues
that are outside of the CNS [49,50,51,52,53,54,55,56]. In these
cases receptors for the transmitters are expressed on the non-
neural cell types that respond to them [50,52,57,58]. Viewed from
this perspective the idea that GABA may be a signaling molecule
in developing cell types outside of the nervous system is a
reasonable hypothesis. In this study, we designed a set of
experiments to test the hypothesis that GABA is required in
non-neural cell types for the normal development and morpho-
genesis of the palate and retraction of the umbilical hernia.
In one set of experiments we found that muscimol was able to
suppress the cleft palate phenotype in the Gad1 and Viaat mutant
mice. The ability of muscimol to suppress or rescue the non-neural
Figure 4. The developing palatal shelves do not express Viaat
transcripts. RNA from dissected E13.5 and E14.5 brain tissue (Brain) or
E13.5 and E14.5 dissected palate shelves (Palate) was analyzed by RT-
PCR using primers corresponding to the Viaat, Gad1, Gabrb3 and Gapdh
coding sequences. For each tissue and stage RT-PCR was performed
with cDNA (+) or with RNA that had not been reverse transcribed (2)t o
control for non-specific amplification. Gapdh was used as a positive
control.
doi:10.1371/journal.pone.0009758.g004
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activation of multimeric GABAA receptors was sufficient to
provide normal function. The ability of muscimol to rescue
suggests that it can substitute for the signal that is normally
generated via the activity of the Gad1 or Viaat genes. The simplest
explanation for the rescue is that the muscimol was acting on
multimeric GABAA receptors in the developing CNS. On the
other hand, if muscimol was acting on non-neural cells then
GABAA receptor subunit transcripts would be expressed in these
cells, presumably in cells adjacent to Gad1 expressing cells.
Although we detected Gabrb3 transcripts in palate RNA by RT-
PCR we have not been able to detect localized expression of the
Gabrb3 mRNA by in situ hybridization. In addition, surveys of gene
expression in the developing mouse palate have not detected the
expression of any GABAA receptor subunits besides the Gabrb3
subunit [16,35]. Therefore, the rescue of the cleft palate
phenotype in the Viaat and Gad mutants by muscimol is consistent
with the requirement for GABA signaling within the CNS for
normal palate development. However, this point requires
Table 2. Frequency of rescue of cleft palate by muscimol in
Gad1-/- and Viaat-/- mice.
Frequency of Cleft Palate
Genotype PBS
a Muscimol (Viaat) Muscimol (Gad1)
+/+ 0/19 1/21 1/10
+/2 1/46 0/34 1/31
2/2 19/19 16/20 7/14
The frequency of cleft palate is expressed as the number of E17.5 day mice
exhibiting a cleft palate over the total number examined for that injection
condition.
The frequency of cleft palate in Gad1-/- E17.5 mice is 100%. In the case of the
Viaat mutant mice we have examined over 200 newborn or late gestation
embryos and the cleft palate phenotype is present in 100% of the offspring.




Figure 5. In vitro fetal palate explant culture. (A-F) Wild-type palates from Swiss Webster (SW) embryos at E13.5 were dissected and cultured for
2 days. (A-C) View of the oral surface of explants prior to culture (A) and after 1 day (B) or 2 days (C) of culture. (D-F) sections through the palate
explants in shown in panels A-C. (G-I) Normal palatogenesis of the Viaat heterozygous (+/2) (G) and homozygous (2/2) (H) explants after 2 days in
culture. Palate explants from the Gad1 mutant embryo at E13.5 also developed normally during culture for 2 days (I). (J-L) Sections of the palate
explants shown in panels G-I.
doi:10.1371/journal.pone.0009758.g005
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GABA receptor expression within the palatal shelves to confirm
that muscimol rescues the Gad1
lacZ and Viaat
lacZ mutant phenotypes
by acting on receptors in the CNS.
The results of our explant culture experiments and the CNS
specific knockout of Gad1 are also consistent with a requirement
for GABA signaling in the CNS for normal palate and body wall
development. Our explant experiments repeated the results
previously obtained with Gad1 mutant explants [13]and demon-
strated that Viaat mutant oral explants can also undergo palate
shelf elevation and fusion in culture. The ability of the Viaat
mutant oral explants to undergo palatogenesis suggested that the
cleft palate phenotype of Viaat mutants is not due to a defect within
the palate shelves themselves. Consistent with these observations
our CNS specific knockout of Gad1 in neural precursor cells
showed the loss of Gad1 function specifically within the CNS was
sufficient to cause a cleft palate and body wall phenotype. This
genetic result confirms that Gad1 function and GABA signaling
within the CNS is necessary for palate and body wall formation.
In contrast, some previously published studies support a
developmental function for GABA signaling outside of the CNS.
Most of these results came from genetic studies of the gene
encoding the b3 subunit of the GABAA receptor (Gabrb3).
Inactivation of Gabrb3 in mice led to the development of cleft
palate in a proportion of the homozygous offspring [1,2,11]. In
one study the expression of Gabrb3 was driven by the neuron
specific enolase (NSE) regulatory sequences in a genetic back-
ground that lacked Gabrb3 [10]. The authors found that the
development of cleft palate was not suppressed in these transgenic
mice. This result was interpreted as evidence that Gabrb3 function
is required in the palate or other non-neural tissues for normal
palate development [10]. However, no detailed characterization of
the NSE-Gabrb3 temporal and spatial expression pattern in the
transgenic embryos was provided. This is important since NSE
transgenes can be subject to position effects resulting in very large
differences in the spatial expression pattern of expression within
the CNS between different transgenic lines [59,60]. In addition the
expression of NSE transgenes is minimal at E13.5–14.5 during the
time of palate elevation and fusion [61]. In fact, NSE sequences
are used to drive gene expression in postmitotic neurons during
later stages of development [62]. Without additional information it
is not possible to know whether Gabrb3 was being expressed early
enough in the NSE-Gabrb3 transgenic lines tested in this previous
study.
A second set of observations supporting a developmental
function for GABA in non-neural tissues comes from studies of a
neuron-specific knockout of the Gabrb3 gene [11]. In these
experiments, a floxed allele of the Gabrb3 gene was inactivated
specifically in neurons by crossing to a synapsin-Cre transgenic
line [11,63,64]. The authors observed that the inactivation of
Gabrb3 specifically in neurons resulted in normal palate develop-
ment in the mice. Although the synapsin-Cre (SynCre) line is well
characterized and has been used to generate neuron specific gene
inactivation, the timing of expression may not be ideal for assessing
Gabrb3 function in palate formation. The SynCre transgene is
specifically expressed in postmitotic neurons and is not widely
expressed in the CNS until E13.5 days [63,64,65]. It is likely that
in the SynCre Gabrb3
flox mice the Cre may inactivate the
conditional Gabrb3 allele too late in development to interfere
with palate elevation and fusion which occur during E13.5-E14.5.
This is a particular concern since the authors were relying on the
inactivation of two Gabrb3
flox alleles in the offspring. Unfortunately,
the authors did not monitor Gabrb3 transcript levels in the CNS
and palate of the SynCre Gabrb3
flox/Gabrb3
flox mice or the extent of
Cre mediated recombination of the Gabrb3
flox allele in these
experiments [11].
GABA signaling in the CNS is required for fetal
movement and developmental processes that depend
on fetal movement
Fetal akinesia during human or rodent development has been
shown to cause defective development of several non-neural tissues
and structures in the fetus. For example, it has been shown that
normal lung development requires spontaneous fetal breathing
movements in humans and mice [66,67,68]. In humans
developmental defects caused by fetal akinesia include multiple
pterygium syndrome (OMIM #265000 and #253290) and the
fetal akinesia deformation sequence (FADS; OMIM #208150).
The phenotypes associated with these syndromes include pulmo-
nary hypoplasia, craniofacial defects, joint contractures, limb
defects, skeletal defects, webbing of the skin (pterygia) and cardiac
defects. Studies have suggested that in some cases FADS is found
in infants born to mothers who have myasthenia gravis, an
autoimmune disorder that affects acetylcholine receptors in the
neuromuscular junction [69,70]. Recent work has tied several
human FADS and multiple pterygium syndrome cases to
mutations in nicotinic acetylcholine receptors as well as mutations
in RAPSN a protein that is associated with acetylcholine receptors
[71,72,73]. This demonstrates that defects in neuromuscular
junction components can lead to non-neural developmental
defects. These reports provide genetic evidence that mutations in
genes required for neuromuscular function can cause a spectrum
of non-neural defects.
Within this context, the craniofacial and body wall phenotypes
found in Gad1 and Viaat knockouts can be understood as additional
examples of non-neural phenotypes caused by changes in fetal
CNS function that in turn lead to changes in fetal muscle tone or
fetal movements. Previous work has shown that fetal movements
during palate formation are impaired in the Gad1 mutant mice
[12]. Although the phenotypes are secondary defects caused by the
primary defect of disrupted GABA signaling in the CNS, they are
fully penetrant developmental defects that are similar to some of
the most common developmental defects seen in humans. To
develop a comprehensive understanding of the origins of defects in
human development it is important to understand the diverse
mechanisms, both primary and secondary, that can cause or
Figure 6. Specific inactivation of Gad1 in the CNS of Gad1
flox/
Gad1
lacZ NesCre E14.5 day old embryos. RT-PCR analysis of RNA
extracted from dissected palate shelves (Palate) or brain (Brain). The
genotype of the tissue is indicated above. For each sample PCR
amplification was performed with cDNA (+ lanes) as well as RNA that
had not been reverse transcribed (- lanes).
doi:10.1371/journal.pone.0009758.g006
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seen in the Gad1 and Viaat homozygous mice are part of a larger
spectrum of developmental defects and disorders that are caused
by impaired or absent fetal movement. Our work suggests that
disruptions of GABA signaling during development could interfere
with any one of several developmental processes that depend on
fetal movement.
In this context is intriguing that there are correlations between
the timing of initial fetal movements in mice or humans and the
initiation of palatogenesis. In mice, palate elevation and fusion
occur at the same time as the first fetal movements are detected
[12]. In humans fetal movements start at 7–8 weeks, with
breathing and hiccup like movements initiating at 8–9 weeks
[74]. This coincides with the time of palate shelf elevation during
the 8th week of human development ([75]). The similarity in
timing of human palate elevation and the initiation of fetal
movements suggests that alterations in GABA signaling could
interfere with human palate development or the development of
any other structure or tissue that develops after the initiation of
fetal movements. So far, genetic studies have detected weak
associations between Gad1 or Gabrb3 alleles and human oral clefts
[7,8,9]. Perhaps the weak association of Gad1 and Gabrb3 with oral
clefts is due to the fundamental requirement for normal GABA
neurotransmission for late fetal or neonatal viability. This would
eliminate individuals who are homozygous for null or strong loss of
function alleles of Gabrb3 or Gad1 from the populations sampled for
these studies.
In conclusion, our work provides multiple lines of evidence that
the non-neural developmental defects in Gad1 and Viaat mutant
mice are due to a requirement for GABA signaling in the CNS
during mouse fetal development. The non-neural defects in these
mice are most likely due to defects in fetal movement caused by
CNS dysfunction and appear to be part of a spectrum of defects
caused by abnormalities in fetal movements. Our results help to
clarify the mechanism leading to cleft palate in the Gad1 and Viaat
knockout mice and suggest that defects in fetal movement caused
by alterations in fetal neuronal GABA signaling may lead to
similar defects in humans.
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